- Home
- ZWS vs CORT Comparison
ZWS vs CORT Comparison
Compare ZWS & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZWS | CORT |
|---|---|---|
| Founded | 1891 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 7.6B |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | ZWS | CORT |
|---|---|---|
| Price | $47.15 | $88.23 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $47.20 | ★ $139.00 |
| AVG Volume (30 Days) | ★ 736.4K | 663.7K |
| Earning Date | 10-28-2025 | 11-04-2025 |
| Dividend Yield | ★ 0.93% | N/A |
| EPS Growth | ★ 42.52 | N/A |
| EPS | ★ 1.12 | 0.87 |
| Revenue | ★ $1,659,400,000.00 | $741,172,000.00 |
| Revenue This Year | $8.97 | $23.79 |
| Revenue Next Year | $5.27 | $40.97 |
| P/E Ratio | ★ $42.16 | $99.75 |
| Revenue Growth | 6.88 | ★ 17.92 |
| 52 Week Low | $27.74 | $49.00 |
| 52 Week High | $50.03 | $117.33 |
Technical Indicators
Market Signals| Indicator | ZWS | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 52.09 | 68.54 |
| Support Level | $45.87 | $81.31 |
| Resistance Level | $48.31 | $87.19 |
| Average True Range (ATR) | 1.01 | 2.86 |
| MACD | -0.01 | 0.74 |
| Stochastic Oscillator | 47.35 | 93.81 |
Price Performance
Historical ComparisonAbout ZWS Zurn Elkay Water Solutions Corporation
Zurn Elkay Water Solutions Corp designs procures, manufactures, and markets a range of clean water solutions for drinking water, hygiene, and sustainable water management. The company's product portfolio includes professional-grade water control and safety, water distribution and drainage, drinking water, finish plumbing, hygienic, environmental and site works products for public and private spaces.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.